• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为促智剂的哌嗪:携带亲水性取代基的强效认知增强剂DM235的新衍生物。

Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.

作者信息

Martino Maria Vittoria, Guandalini Luca, Di Cesare Mannelli Lorenzo, Menicatti Marta, Bartolucci Gianluca, Dei Silvia, Manetti Dina, Teodori Elisabetta, Ghelardini Carla, Romanelli Maria Novella

机构信息

University of Florence, Department of Neuroscience, Psychology, Drug Research and Child's Health, Section of Pharmaceutical and Nutraceutical Sciences, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.

University of Florence, Department of Neuroscience, Psychology, Drug Research and Child's Health, Section of Pharmacology and Toxicology, Viale Gaetano Pieraccini 6, 50100 Florence, Italy.

出版信息

Bioorg Med Chem. 2017 Mar 15;25(6):1795-1803. doi: 10.1016/j.bmc.2017.02.019. Epub 2017 Feb 16.

DOI:10.1016/j.bmc.2017.02.019
PMID:28238510
Abstract

The piperazine ring of the potent nootropic drug DM235 has been decorated with H-bond donor and acceptor groups (CHOH, CHOMe, CHOCOMe, COOEt); the aim was to insert new functional groups, suitable for further chemical manipulation. The influence of these modifications on nootropic activity was assessed by means of the mouse passive avoidance test; some of the newly synthesized molecules (alcohol 7b, acetate 8b and ester 10d) showed interesting in vivo potency. This makes it possible to use these functional groups for adding other residues, in order to increase molecular diversity, or for anchoring a biotin group, to obtain compounds useful to capture the biological target. Moreover, the new compounds will improve our knowledge of structure activity relationships of this family of drugs.

摘要

强效益智药DM235的哌嗪环已用氢键供体和受体基团(CHOH、CHOMe、CHOCOMe、COOEt)修饰;目的是引入适合进一步化学操作的新官能团。通过小鼠被动回避试验评估了这些修饰对益智活性的影响;一些新合成的分子(醇7b、乙酸酯8b和酯10d)显示出有趣的体内活性。这使得可以使用这些官能团添加其他残基,以增加分子多样性,或锚定生物素基团,从而获得可用于捕获生物靶点的化合物。此外,新化合物将增进我们对该类药物构效关系的了解。

相似文献

1
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents.作为促智剂的哌嗪:携带亲水性取代基的强效认知增强剂DM235的新衍生物。
Bioorg Med Chem. 2017 Mar 15;25(6):1795-1803. doi: 10.1016/j.bmc.2017.02.019. Epub 2017 Feb 16.
2
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.作为促智药的取代哌嗪:与认知增强剂DM235结构相关的2-或3-苯基衍生物。
Bioorg Med Chem Lett. 2015 Apr 15;25(8):1700-1704. doi: 10.1016/j.bmcl.2015.03.009. Epub 2015 Mar 12.
3
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs.环大小对 DM235 和 MN19 这两种强效益智药认知增强活性的影响。
Bioorg Med Chem Lett. 2012 Mar 1;22(5):1936-9. doi: 10.1016/j.bmcl.2012.01.045. Epub 2012 Jan 25.
4
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.DM235(舒尼菲胺):一种具有作为认知增强剂潜力的新型益智药。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):419-26. doi: 10.1007/s00210-002-0577-3. Epub 2002 May 15.
5
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers.新型 sunifiram 和 sapunifiram 类似物的设计、合成及促智活性研究,这两种化合物均为强效认知增强剂。
Bioorg Med Chem. 2009 Nov 1;17(21):7606-14. doi: 10.1016/j.bmc.2009.08.055. Epub 2009 Sep 3.
6
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators.新型 DM232(unifiram)和 DM235(sunifiram)类似物作为认知调节剂的设计、合成及初步药理学评价
Bioorg Med Chem. 2008 Dec 1;16(23):10034-42. doi: 10.1016/j.bmc.2008.10.017. Epub 2008 Oct 11.
7
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.新型强效认知增强药物unifiram(DM232)和sunifiram(DM235)的构效关系研究
Bioorg Med Chem. 2004 Jan 2;12(1):71-85. doi: 10.1016/j.bmc.2003.10.025.
8
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity.对1,4 - 二氮杂双环[4.3.0]壬 - 9 - 酮进行分子简化得到的哌嗪衍生物保持了较高的促智活性。
J Med Chem. 2000 Nov 16;43(23):4499-507. doi: 10.1021/jm000972h.
9
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.新型强效认知增强剂DM232(unifiram)和DM235(sunifiram)的药理学特性
CNS Drug Rev. 2006 Spring;12(1):39-52. doi: 10.1111/j.1527-3458.2006.00039.x.
10
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent.强效认知增强剂unifiram(DM232)对映体的对映选择性合成及初步药理学评价
Med Chem. 2005 Sep;1(5):473-80. doi: 10.2174/1573406054864142.

引用本文的文献

1
Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.健康个体使用“聪明药”(益智药)的获益和危害。
Drugs. 2022 Apr;82(6):633-647. doi: 10.1007/s40265-022-01701-7. Epub 2022 Apr 2.
2
Resolution of co-eluting isomers of anti-inflammatory drugs conjugated to carbonic anhydrase inhibitors from plasma in liquid chromatography by energy-resolved tandem mass spectrometry.采用能量分辨串联质谱法从液相色谱中的血浆中分离与碳酸酐酶抑制剂缀合的抗炎药共洗脱异构体。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):671-679. doi: 10.1080/14756366.2018.1445737.